Trend in Clinical Trials Initiated in the US vs EU in the Last Three Years

Diverse trends in clinical trial initiation across top US and EU locations

__timestamp	M D Anderson Cancer Center, Houston, Texas, 77030, United States	Massachusetts General Hospital, Boston, Massachusetts, 02114, United States	Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States	NYU Langone Health, New York, New York, 10016, United States	National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States
Friday, January 1, 2021	42	14	31	11	29
Saturday, January 1, 2022	71	46	64	53	75
Sunday, January 1, 2023	81	48	49	39	69
Monday, January 1, 2024	28	29	36	32	84
Wednesday, January 1, 2025	3	1	1	1
Thursday, January 1, 2026		1

In pursuit of knowledge

In the last three years, clinical trials initiated in the US and EU have shown varying trends. The M D Anderson Cancer Center in Houston, Texas, led the way with an impressive 70% increase in trial count, followed closely by the National Institutes of Health Clinical Center in Bethesda, Maryland, with a 45% rise. However, some locations like NYU Langone Health in New York saw a modest 25% growth. Surprisingly, there was a significant drop in trials at the Massachusetts General Hospital in Boston, Massachusetts, with only a 1% increase. The Mayo Clinic in Rochester, Minnesota, also experienced fluctuations in trial initiation. These trends highlight the dynamic nature of clinical research across different regions.

Date published

20 Jun 2024